198 related articles for article (PubMed ID: 29949618)
1. Serum MMP-2 as a potential predictive marker for papillary thyroid carcinoma.
Shi Y; Su C; Hu H; Yan H; Li W; Chen G; Xu D; Du X; Zhang P
PLoS One; 2018; 13(6):e0198896. PubMed ID: 29949618
[TBL] [Abstract][Full Text] [Related]
2. Predictive Significance of Serum MMP-9 in Papillary Thyroid Carcinoma.
Xu D; Su C; Guo L; Yan H; Wang S; Yuan C; Chen G; Pang L; Zhang N
Open Life Sci; 2019 Jan; 14():275-287. PubMed ID: 33817161
[TBL] [Abstract][Full Text] [Related]
3. Predictive significance of serum dipeptidyl peptidase-IV in papillary thyroid carcinoma.
Zhang N; Cong X; Zhou D; Guo L; Yuan C; Xu D; Su C
Cancer Biomark; 2019; 24(1):7-17. PubMed ID: 30594915
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of matrix metalloproteinase-9 predicts papillary thyroid carcinoma prognosis.
Liu X; Su C; Xu J; Zhou D; Yan H; Li W; Chen G; Zhang N; Xu D; Hu H
Oncol Lett; 2019 Feb; 17(2):2308-2316. PubMed ID: 30675296
[TBL] [Abstract][Full Text] [Related]
5. Preoperative platelet distribution width-to-platelet ratio combined with serum thyroglobulin may be objective and popularizable indicators in predicting papillary thyroid carcinoma.
Jin J; Wu G; Ruan C; Ling H; Zheng X; Ying C; Zhang Y
J Clin Lab Anal; 2022 Jun; 36(6):e24443. PubMed ID: 35441746
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical levels of matrix metalloproteinase-2 and CD44 variant 6 protein in the diagnosis and lateral cervical lymph node metastasis of papillary thyroid carcinoma.
Wu G; Zhou Y; Li T; Guo J; Zhou Z
J Int Med Res; 2013 Jun; 41(3):816-24. PubMed ID: 23685894
[TBL] [Abstract][Full Text] [Related]
7. Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.
Chang Q; Zhang J; Wang Y; Li H; Du X; Zuo D; Yin D
Front Endocrinol (Lausanne); 2022; 13():937049. PubMed ID: 35909521
[TBL] [Abstract][Full Text] [Related]
8. Predictive Value of Serum Thyroglobulin for Structural Recurrence Following Lobectomy for Papillary Thyroid Carcinoma.
Xu S; Huang H; Zhang X; Huang Y; Guan B; Qian J; Wang X; Liu S; Xu Z; Liu J
Thyroid; 2021 Sep; 31(9):1391-1399. PubMed ID: 34340593
[No Abstract] [Full Text] [Related]
9. Serum Matrix metalloproteinase-9 (MMP-9) can help identify patients with papillary thyroid cancer at high risk of persistent disease: Value and limitations of a potential marker of neoplasia.
Dobrescu R; Picu C; Caragheorgheopol A; Manda D; Ioachim D; Goldstein A; Badiu C
Cancer Biomark; 2020; 29(3):337-346. PubMed ID: 32716342
[TBL] [Abstract][Full Text] [Related]
10. Using Diffusion-Weighted MRI to Predict Central Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Feasibility Study.
Zhang H; Hu S; Wang X; Liu W; He J; Sun Z; Ge Y; Dou W
Front Endocrinol (Lausanne); 2020; 11():326. PubMed ID: 32595598
[No Abstract] [Full Text] [Related]
11. Using a nomogram based on preoperative serum fibrinogen levels to predict recurrence of papillary thyroid carcinoma.
Jianyong L; Zhihui L; Rixiang G; Jingqiang Z
BMC Cancer; 2018 Apr; 18(1):390. PubMed ID: 29621982
[TBL] [Abstract][Full Text] [Related]
12. The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer.
Zarkesh M; Zadeh-Vakili A; Akbarzadeh M; Fanaei SA; Hedayati M; Azizi F
BMC Cancer; 2018 Dec; 18(1):1199. PubMed ID: 30509240
[TBL] [Abstract][Full Text] [Related]
13. Values of ultrasound features and MMP-9 of papillary thyroid carcinoma in predicting cervical lymph node metastases.
Zhang Y; Luo YK; Zhang MB; Li J; Li CT; Tang J; Li JL
Sci Rep; 2017 Jul; 7(1):6670. PubMed ID: 28751724
[TBL] [Abstract][Full Text] [Related]
14. Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma.
Huang FQ; Li J; Jiang L; Wang FX; Alolga RN; Wang MJ; Min WJ; Ma G; Zhao YJ; Wang SL; Yu Y; Chen X; Zhu D; Zhu J; Wang G; Xia T; Sang JF; Lai MD; Li P; Zhu W; Qi LW
Int J Cancer; 2019 Feb; 144(4):868-876. PubMed ID: 30318614
[TBL] [Abstract][Full Text] [Related]
15. Predicting cervical lymph node metastasis in patients with papillary thyroid cancer (PTC) - Why contrast-enhanced ultrasound (CEUS) was performed before thyroidectomy.
Zhan J; Diao X; Chen Y; Wang W; Ding H
Clin Hemorheol Microcirc; 2019; 72(1):61-73. PubMed ID: 30452407
[TBL] [Abstract][Full Text] [Related]
16. Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.
Chang YW; Kim HS; Jung SP; Kim HY; Lee JB; Bae JW; Son GS
Int J Clin Oncol; 2016 Oct; 21(5):862-868. PubMed ID: 26837274
[TBL] [Abstract][Full Text] [Related]
17. The Clinicopathological Features of Papillary Thyroid Carcinoma Patients with Positive Hepatitis B Surface Antigen.
Zhong Z; Yuan J; Chen X; Chen Z; Du J; Chen Z; Kuang J; Cong S; Li J; Wu Z
Oncol Res Treat; 2020; 43(1-2):27-33. PubMed ID: 31722345
[TBL] [Abstract][Full Text] [Related]
18. Suspicious ultrasound characteristics correlate with multiple factors that predict central lymph node metastasis of papillary thyroid carcinoma: Significant role of HBME-1.
Jianming L; Jibin L; Linxue Q
Eur J Radiol; 2020 Feb; 123():108801. PubMed ID: 31918249
[TBL] [Abstract][Full Text] [Related]
19. Combination of serum microRNAs and ultrasound profile as predictive biomarkers of diagnosis and prognosis for papillary thyroid microcarcinoma.
Zhang Y; Pan J; Xu D; Yang Z; Sun J; Sun L; Wu Y; Qiao H
Oncol Rep; 2018 Dec; 40(6):3611-3624. PubMed ID: 30542708
[TBL] [Abstract][Full Text] [Related]
20. Significance of distance between tumor and thyroid capsule as an indicator for central lymph node metastasis in clinically node negative papillary thyroid carcinoma patients.
Seong CY; Chai YJ; Lee SM; Kim SJ; Choi JY; Lee KE; Hwang KT; Park SW; Yi KH
PLoS One; 2018; 13(7):e0200166. PubMed ID: 30016353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
